Views 128
Citations 0
Mar 2012

Ordering of Alzheimer Disease Biomarkers

Author Affiliations

Author Affiliations: New York University School of Medicine, New York.

Arch Neurol. 2012;69(3):414-415. doi:10.1001/archneurol.2011.2906

In a recent paper published in the Archives of Neurology, Jack et al1 provided evidence in support of an hypothesized temporal ordering of selected biologic features of Alzheimer disease using surrogate biomarkers.

There are indisputable merits to their work. The authors reported on the prevalence of abnormal biomarker values for a large group of subjects representing 3 different stages of cognitive impairment. They used 2 well-defined cerebrospinal fluid and 1 magnetic resonance imaging biomarkers in a 1-year follow-up design. The presented cut values for abnormality were defined based on data independently validated at postmortem. However, despite these attributes, we believe for several reasons that the authors failed to deliver full support for their model.

First Page Preview View Large
First page PDF preview
First page PDF preview